ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Globalworth declares 7-cent interim dividend with scrip option

Real estate firm Globalworth sets 7 cents per share interim payout for H1 2026, offering shareholders a 20% discounted scrip alternative under €10m annual cash cap.

PA
Priya Anand · Equities & Earnings Desk · 30 Aug 2026 · 05:44 · 1 min read
Share
Globalworth declares 7-cent interim dividend with scrip option

Globalworth Real Estate Investments Limited, a London-listed real estate investment trust focused on Central and Eastern Europe, declared an interim dividend of 7 cents per ordinary share for the six months ended June 30, 2026.

The board also introduced a scrip dividend option, allowing shareholders to receive new ordinary shares at a 20% discount to the five-day average market price starting from the ex-dividend date. The reference price for the scrip shares will be announced on September 10.

The dividend is subject to a €10.0 million annual cash payout limit, with approximately €0.3 million already distributed in March 2026, leaving up to €9.7 million available for this interim payment. Major shareholders—Zakiono Enterprises Ltd, CPI Property Group S.A., and Growthpoint Properties Ltd—collectively holding 92.6% of the issued share capital, have agreed to elect for the share alternative on 53.9% of the capital, reducing the cash portion to roughly €8.2 million.

Key dates include an ex-dividend date of September 3, record date of September 4 at 18:00, and a deadline to opt for the scrip alternative on September 18 at 18:00. Cash and share dividends are scheduled for credit or payment on October 9.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT